Chinook Therapeutics Inc (NASDAQ:KDNY)

22.50
Delayed Data
As of 4:00pm ET
 -0.12 / -0.53%
Today’s Change
11.16
Today|||52-Week Range
23.86
+37.95%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-39.2M-91.1M-91.9M-95.4M
 
 
 
 
 
Depreciation723.0K2.6M4.0M5.0M
 
 
 
 
 
Total Other Cash Flow35.2M12.8M19.8M21.1M
 
 
 
 
 
Funds From Operations-3.3M-83.6M-61.9M-69.5M
 
 
 
 
 
Funds From/For Other Operating Expenses-158.1M2.5M27.0M-730.0K
 
 
 
 
 
Net Cash Flow - Operating Activities154.8M-86.1M-88.9M-68.8M
 
 
 
 
 
 
InvestingIncrease In Investments-359.4M-360.0M-260.4M-227.0M
 
 
 
 
 
Decrease In Investments77.9M351.3M354.5M268.7M
 
 
 
 
 
Capital Expenditures-2.2M-23.9M-5.2M-2.4M
 
 
 
 
 
Fixed Asset Disposal------41.0K
 
 
Net Assets From Acquisitions -14.3M0.000.00--
 
 
Net Cash Flow Investing-298.0M-32.5M88.9M39.4M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale173.6M37.8M81.2M1.5M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing572.0K5.3M828.0K529.0K
 
 
 
 
 
Other Uses - Financing----0.003.5M
 
 
Net Cash Flow - Financing174.2M43.1M82.1M-1.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----543.0K-457.0K
 
 
 
 
Net Change In Cash31.0M-75.5M82.1M-30.8M